NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560 | -22.1% | 34,646 | +100.0% | 0.00% | -25.0% |
| Q2 2023 | $719 | -23.0% | 17,323 | +11.6% | 0.00% | -20.0% |
| Q1 2023 | $934 | -18.0% | 15,523 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $1,139 | -99.9% | 15,523 | +2.6% | 0.01% | -12.5% |
| Q3 2022 | $1,149,000 | +9.3% | 15,123 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $1,051,000 | -10.2% | 15,123 | +7.1% | 0.01% | 0.0% |
| Q1 2022 | $1,170,000 | -3.4% | 14,123 | -12.4% | 0.01% | +16.7% |
| Q4 2021 | $1,211,000 | -65.3% | 16,123 | +2.5% | 0.01% | -66.7% |
| Q2 2021 | $3,488,000 | +26.6% | 15,723 | -1.3% | 0.02% | +5.9% |
| Q4 2020 | $2,755,000 | – | 15,923 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |